PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Bilirakis, Gus M. [R-FL-12]

Rep. Bilirakis, Gus M. [R-FL-12]

United States · Official source

Records

3,366 records where Rep. Bilirakis, Gus M. [R-FL-12] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 9892 (119th)referred

Stop EU Overreach Act

United States · United States Congress · 23 July 2026

Bill· HRH.R. 9858 (119th)referred

STRATA Act of 2026

United States · United States Congress · 22 July 2026

Bill· HRH.R. 9590 (119th)referred

SAFE for Manatees Act

United States · United States Congress · 2 July 2026

Bill· HRH.R. 9541 (119th)referred

FIREWALL Act

United States · United States Congress · 30 June 2026

Bill· HRH.R. 9237 (119th)open

Take Care of America’s Veterans Act

United States · United States Congress · 10 June 2026

Take Care of America's Veterans Act This bill addresses veterans’ benefits, health care, counseling, Department of Veterans Affairs (VA) personnel, VA infrastructure, and the Veterans Community Care Program (VCCP). The bill modifies various compensation programs for veterans, including by (1) allowing concurrent receipt of disability compensation and military retired pay for certain retirees with a combat-related disability, (2) extending entitlement for various benefits and services to remarried surviving spouses, (3) increasing the rate of dependency and indemnity compensation, and (4) establishing a supplemental monthly allowance for certain disabled veterans. The bill also addresses VA education and training benefits, including by (1) modifying which independent study programs are covered under veterans’ educational assistance benefits, (2) requiring Transition Assistance Program counseling to include a presentation about VA benefits, and (3) increasing the housing allowance rate for individuals pursuing apprenticeships. The bill revises health care provisions, including by (1) expanding support and assistance provided to family caregivers, (2) extending the Staff Sergeant Parker Gordon Fox Suicide Prevention Grant Program, and (3) expanding the scope of VA mental health research. Among other elements, the bill revises VA disability ratings for sleep apnea and tinnitus; expands eligibility for a memorial headstone or marker for the spouse, surviving spouse, child, or dependent of a veteran or member of the Armed Forces; addresses the administration of the VCCP and codifies the eligibility standards; establishes a standardized screening process for priority or routine admission to certain mental health care programs; and addresses VA personnel, hiring, and infrastructure matters.

Bill· HRH.R. 9129 (119th)referred

GUARD Act of 2026

United States · United States Congress · 3 June 2026

Bill· HRH.R. 9094 (119th)referred

Florida Freeze Disaster Assistance Act of 2026

United States · United States Congress · 2 June 2026

Florida Freeze Disaster Assistance Act of 2026 This bill provides $3.5 billion in emergency funding for the Department of Agriculture (USDA) to provide block grants to certain states for losses of revenue, quality, or production of crops (including crops prevented from planting), trees, bushes, and vines as a consequence of a freeze or cold weather conditions. The bill specifies that the funding may only be made available for losses occurring in counties that received a disaster designation for freeze and related cold weather conditions issued by USDA on March 4, 2026. (This includes certain counties in Alabama, Florida, and Georgia.) The bill requires the assistance provided by the bill to include compensation to producers for losses of multi-year crops. The funds provided by this bill must be made available upon the request of a state department of agriculture or other appropriate state agency.

Bill· HRH.R. 8737 (119th)referred

Never Fight Alone Act

United States · United States Congress · 12 May 2026

Resolution· HRESH.Res. 1252 (119th)passed

Resolution memorializing law enforcement officers killed in the line of duty.

United States · United States Congress · 4 May 2026

This resolution expresses support for police officers and other law enforcement personnel. The resolution further recognizes law enforcement officers across the United States in the pursuit of preserving safe and secure communities; the need to ensure that such officers have the equipment, training, and resources necessary to protect their health and safety while they are protecting the public; and the law enforcement community for acts of sacrifice and heroism. The resolution expresses condolences and appreciation to the loved ones of each law enforcement officer who has made the ultimate sacrifice in the line of duty.

Bill· HRH.R. 8471 (119th)referred

PRIMATE Act

United States · United States Congress · 23 April 2026

Bill· HRH.R. 8280 (119th)referred

SEPTIC Act

United States · United States Congress · 14 April 2026

Bill· HRH.R. 8239 (119th)referred

SACRED Act

United States · United States Congress · 9 April 2026

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Resolution· HRESH.Res. 1143 (119th)referred

Recognizing the 205th anniversary of the War of Greek Independence.

United States · United States Congress · 27 March 2026

This resolution congratulates the people of Greece as they celebrate the 205th anniversary of the War of Greek Independence. The resolution also expresses support for the principles of democracy, human rights, and the rule of law to which the people of the United States and Greece are committed.

Bill· HRH.R. 8095 (119th)referred

Ensuring Medicaid Continuity for Children in Foster Care Act of 2026

United States · United States Congress · 26 March 2026

Ensuring Medicaid Continuity for Children in Foster Care Act of 2026 This bill allows states to receive federal Medicaid payment for services provided to foster care children in qualified residential treatment programs (i.e., programs with trauma-informed treatment models that address the needs of children with serious emotional or behavioral disorders or disturbances).

Bill· HRH.R. 7994 (119th)reported

HERO Act

United States · United States Congress · 19 March 2026

Bill· HRH.R. 8000 (119th)referred

END 7-OH Act

United States · United States Congress · 19 March 2026

Bill· HRH.R. 7871 (119th)referred

MVP Act

United States · United States Congress · 9 March 2026

Medicaid VBPs for Patients Act or the MVP Act This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. ( Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.) The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes. Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to issue guidance on how state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.